Dr. Kumar has been President and CEO since September 2001, and has been a Director since September 2000. Previously, Dr. Kumar was Vice President of Life Sciences of Acacia Research Corp. (NASDAQ: ACRI). From January 1999 to February 2000, Dr. Kumar was the founding President and Chief Executive Officer of Signature BioSciences, Inc., a life science company developing technology for advanced research in genomics, proteomics and drug discovery. From January 1998 to December 1999, Dr. Kumar was an Entrepreneur in Residence with Oak Investment Partners, a venture capital firm. From October 1996 to January 1998, Dr. Kumar was a Senior Manager at IDEXX Laboratories, Inc., a biotechnology company. From October 1993 to September 1996, Dr. Kumar was Head of Research & Development for Idetek Corporation, which was later acquired by Idexx Laboratories, Inc. Dr. Kumar received his bachelor's degree in chemistry from Occidental College. After joint studies at Stanford University and the California Institute of Technology, he received his Ph.D. from Caltech in 1991. He also completed a post-doctoral fellowship at Harvard University in 1993. Dr. Kumar also serves as a director of Aeolus Pharmaceuticals.

Dr. Anderson has been Chief Operating Officer since February 2004. From April 2003 through March 2004, Dr. Anderson served as our Vice President, Software Development and Engineering. From April 2000 through April 2003, Dr. Anderson served as our Vice President, Software Development. Dr. Anderson also served as the company's first President from October 1995 to January 1997. Prior to joining CombiMatrix, Dr. Anderson co-founded Acacia Research Corporation, and from January 1993 to August 1997, served as Acacia's Vice President, Research and Development. Dr. Anderson received a B.S.E. in nuclear engineering from the University of Michigan in 1985, an M.S. in applied physics from the California Institute of Technology in 1987, and a Ph.D. in computation and neural systems from the California Institute of Technology in 1993.

Mr. Akin was appointed to our board of directors in December of 2006. He has been the Managing General Partner of four private investment funds (Talkot Partners I, Talkot Partners II, LLC, Talkot Crossover Fund, L.P., and Talkot Capital) since 1996. Mr. Akin previously served in a variety of capacities for Merrill Lynch and Co., including Managing Director of Western Regional Sales from 1986 - 1994. Mr. Akin holds a B.A. from the University of California at Santa Cruz and attended the University of California at Los Angeles Graduate School of Business. Mr. Akin also serves as a director of Dynex Capital, Inc.

Mr. Currie was appointed to our board of directors in December of 2006. Since July 1999, Mr. Currie has been an independent venture capital consultant. From February 1993 to July 1998, Mr. Currie was a partner of MK Global Ventures, a venture capital limited partnership. Mr. Currie received a B.S.I.E. from the Georgia Institute of Technology and an M.B.A. from Harvard Business School.

Dr. Abeles is the founder of MedVest, Inc., which has provided consulting services to health care and high technology companies since 1980 and where he has served as President since 1982. Since 1998, he has served as Chairman of UniMedica Inc., a web-enabled Medical School education consulting and publishing firm. Since 1992, Dr. Abeles has been the general partner of Northlea Partners, Ltd., an investment and venture capital firm. Since 1998, he has also served as Assistant Professor, Clinical Pharmacology and Therapeutics at the International University of Health Sciences. Dr. Abeles has been a member of the Boards of Directors of the following companies since the date noted: CombiMatrix Molecular Diagnostics, Inc. (1996), DUSA Pharmaceuticals, Inc. (1995), I-Flow Corporation (1987), and Oryx Technology (1989). Since 1997, Dr. Abeles has served as a Director of Higuchi Bio-Science Institute, University of Kansas, and since 2001 has served as Director of College of Chemistry Advisory Board, University of California Dr. Abeles joined our Board of Directors in December 2006, and has served on our CombiMatrix Scientific Advisory Board since June 2006.